October 21, 2023
Tag: Ethan Basch
July 1, 2023
OncLive: FOLFOX Produces Varying Toxicity Profile vs Chemoradiation in Rectal Cancer
June 26, 2023
Oncology Nursing News: PRO Analysis of PROSPECT Trial Reveals Distinct Toxicity Profiles With FOLFOX vs Chemoradiation in Rectal Cancer
June 19, 2023
ASCO Post: Patient-Reported Outcomes From the PROSPECT Trial: Neoadjuvant FOLFOX vs Chemoradiation for Locally Advanced Rectal Cancer
June 4, 2023
Study provides guidance on quality-of-life choices for rectal cancer treatments
A multi-institutional study comparing treatment options for locally advanced rectal cancer while collecting patient-reported treatment side-effects has generated insights patients can use to make more informed quality-of-life treatment choices.
June 4, 2023
New York Times: Rectal Cancer Patients Could Be Spared the Brutal Effects of Radiation
June 4, 2023
Medscape: Omitting Radiation in Rectal Cancer: ‘Less Is More’
July 26, 2022
Patient Engagement HIT: Language Barriers Limit Patient-Reported Outcomes in Cancer Care
July 22, 2022
Pink Sheet: Patient-Reported Outcomes: Open-Label Trials Can Be Designed To Minimize Bias, US FDA Says
June 15, 2022